Office/HQPharma & medical

Nakashima Health Force to relocate and build new headquarters/factory in Akaiwa, Okayama

Nakashima Health Force Co., Ltd.Akaiwa, OkayamaPublished Jul 24, 2026

Investment¥10B

PhasePlanned

StartMay 2026

CompletionDec 2027

Construction

Today

20272028

About 14 months to scheduled completion.

Orthopedic medical device maker Nakashima Health Force will relocate its head office and factory to a new site in the Iwata district of Akaiwa City, Okayama Prefecture, investing approximately JPY 10 billion. The new facility will triple floor space versus the current plant, adding labor-saving/automation equipment and metal 3D printers, plus solar power, backup generators and water tanks for disaster resilience.

Project facts

Owner: Nakashima Health Force Co., Ltd.
Facility: Office/HQ
Sector: Pharma & medical
Location: Akaiwa, Okayama, Japan
Investment: ¥10B — total, new headquarters and factory
Scale / capacity: site area 37,072 sqm; factory building 11,768 sqm floor area (2-story steel frame); main building 5,918 sqm floor area (3-story steel frame)
Construction start: May 2026
Completion: Dec 2027
Announced: Apr 15, 2026
Themes: renewable-energy

Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.

Also in Okayama5 projects · ¥33.8B disclosedOn the map →

JFE Steel to make large-scale equipment investment in OkayamaJFE Steel CorporationPlanned¥14.8B Okayama Murata Manufacturing to make major equipment investment at its Okayama siteOkayama Murata Manufacturing Co., Ltd.Planned¥9B Power X to begin mass production of Mega Power 4000 grid-scale battery systemsPower X, Inc.Plannedn/d Shinko Kogyo builds new 'Innovation Center' plant and office in Soja CityShinko Kogyo Co., Ltd.Completedn/d

Latest in Pharma & medicalAll Pharma & medical →

Fujifilm to install ADC raw-material manufacturing equipment at Hirono plant

Pharma & medicalFukushimaPlanned2026.10.07

Fujifilm will install payload and linker-payload manufacturing equipment, including reaction vessels, a filtration dryer and a preparative HPLC system, at the Hirono plant in Fukushima. The facility will also add a laboratory for process and analytical-method development, with operations scheduled to begin in 2028, enabling Fujifilm's one-stop domestic ADC CDMO service.

Shikoku Chuken to build new headquarters and research facility in Ayagawa

Pharma & medicalKagawaPlanned2026.10.01

Shikoku Chuken will build a new headquarters facility on land adjacent to its existing headquarters in Ayagawa, Kagawa. The facility will expand research and development using clinical specimens and testing data collected from across Shikoku, along with corporate planning, information processing and administrative functions; operations are scheduled to begin in January 2028.

Olympus completes new B Building at Nagano site for medical-device component production

Pharma & medicalNaganoCompleted¥18B2026.08.21

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & medicalTochigiCompleted2026.08.17

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.